Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229


Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.

Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H.

BMC Infect Dis. 2014 Feb 25;14:106. doi: 10.1186/1471-2334-14-106.


Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Cámara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C.

J Antimicrob Chemother. 2012 Aug;67(8):1858-60. doi: 10.1093/jac/dks162. Epub 2012 May 7.


Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?

Jeverica S, Golparian D, Matičič M, Potočnik M, Mlakar B, Unemo M.

J Antimicrob Chemother. 2014 Jun;69(6):1517-25. doi: 10.1093/jac/dku026. Epub 2014 Feb 16.


Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.

Kovari H, de Melo Oliveira MD, Hauser P, Läuchli S, Meyer J, Weber R, Zbinden R.

BMC Infect Dis. 2013 Dec 26;13:603. doi: 10.1186/1471-2334-13-603.


Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.

Thakur SD, Levett PN, Horsman GB, Dillon JA.

Sex Transm Infect. 2014 Jun;90(4):297-302. doi: 10.1136/sextrans-2013-051229. Epub 2014 Feb 6.


Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.

Thakur SD, Starnino S, Horsman GB, Levett PN, Dillon JR.

J Antimicrob Chemother. 2014 Jun;69(6):1510-6. doi: 10.1093/jac/dkt543. Epub 2014 Feb 13.


Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.

Morita-Ishihara T, Unemo M, Furubayashi K, Kawahata T, Shimuta K, Nakayama S, Ohnishi M.

J Antimicrob Chemother. 2014 Aug;69(8):2086-90. doi: 10.1093/jac/dku118. Epub 2014 Apr 28.


Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.

Jiang FX, Lan Q, Le WJ, Su XH.

BMC Infect Dis. 2017 May 25;17(1):366. doi: 10.1186/s12879-017-2472-z.


Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Lewis DA, Sriruttan C, Müller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M.

J Antimicrob Chemother. 2013 Jun;68(6):1267-70. doi: 10.1093/jac/dkt034. Epub 2013 Feb 14.


Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.


Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.

Serra-Pladevall J, Barberá MJ, Rodriguez S, Bartolomé-Comas R, Roig G, Juvé R, Andreu A.

Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1549-56. doi: 10.1007/s10096-016-2696-7. Epub 2016 Jun 2.


Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.

Lee H, Unemo M, Kim HJ, Seo Y, Lee K, Chong Y.

J Antimicrob Chemother. 2015 Sep;70(9):2536-42. doi: 10.1093/jac/dkv146. Epub 2015 Jun 17.


Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.

Dillon JA, Li H, Sealy J, Ruben M, Prabhakar P; Caribbean GASP Network. Gonococcal Antimicrobial Surveillance Program.

Sex Transm Dis. 2001 Sep;28(9):508-14.


Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.

Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo M.

BMC Infect Dis. 2016 Jul 22;16:353. doi: 10.1186/s12879-016-1673-1.


Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.

Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG.

Antimicrob Agents Chemother. 2011 Feb;55(2):703-12. doi: 10.1128/AAC.00788-10. Epub 2010 Nov 22. Erratum in: Antimicrob Agents Chemother. 2014 Jan;58(1):632.


Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.

Starnino S; GASP-LAC Working Group, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, Hernandez AL, Carbajal JL, Borthagaray G, Payares D, Dillon JA.

Sex Transm Dis. 2012 Oct;39(10):813-21.


Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.

Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M.

Sex Transm Dis. 2012 Apr;39(4):316-23. doi: 10.1097/OLQ.0b013e3182401b69.


Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.

Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G.

Sex Transm Dis. 2013 Jan;40(1):46-51. doi: 10.1097/OLQ.0b013e31827bd64c.


Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.

Lindberg R, Fredlund H, Nicholas R, Unemo M.

Antimicrob Agents Chemother. 2007 Jun;51(6):2117-22. Epub 2007 Apr 9.

Supplemental Content

Support Center